Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000841471) titled 'Tirzepatide for the treatment of concurrent type 1 diabetes and overweight or obesity 2.0 - an open-label randomised crossover trial in adults' on Aug. 5.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Crossover
Type of endpoint: Efficacy
Primary Sponsor: Department of Diabetes, Metabolism & Endocrinology, Royal North Shore Hospital
Condition:
Type 1 Diabetes
Obesity
Overweight
Type 1 Diabetes
Obesity
Overweight
Metabolic and Endocrine - Diabetes
Intervention:
Participants will be randomised 1:1 to receiv...